Welcome to Penn State Hershey Pediatric Hematology/Oncology

The division of Pediatric Hematology/Oncology at Penn State Hershey Children's Hospital includes eleven Pediatric Hematologists/Oncologists and six Ph.D. research faculty. The Division Pediatric Hematology/Oncology is committed to State-of-the-Art Clinical Care, Cutting-Edge Research, and First-Rate Education.

We provide multidisciplinary, comprehensive clinical care. Our physicians are included in the list of Best Doctors in America. The Division of Pediatric Hematology/Oncology participates in clinical trials through the Children's Oncology Group (COG) and the Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC).

Research in the Division of Pediatric Hematology/Oncology is conducted by internationally renowned physician-scientists. Research projects are funded by the National Institutes of Health and various philanthropic organizations. The division of Pediatric Hematology/Oncology has an ACGME-accredited fellowship program.

The clinical and research activities of the Division are supported by the Four Diamonds Fund. The Four Diamonds Pediatric Cancer Research Institute at Penn State College of Medicine was established through the Four Diamonds Endowment.

 

 

Four Diamonds Fund

The Four Diamonds Fund generously supports our oncology patients to defray costs not covered by standard insurance.  The fund provides extensive resources for our outpatient and inpatient units, and supports personnel to assure the best outcomes for our patients. 

The Four Diamonds Fund has been actively involved in funding research conducted at Penn State College of Medicine through grants for projects relating to the causes, prevention, treatment,and cure for pediatric cancer.

In 1998, in an effort to expand their research potential, an initiative was launched to establish the Four Diamonds Pediatric Research Center at Penn State College of Medicine.  Thanks to the generosity of many donors, particularly the Penn State Dance Marathon, this Research Institute now has a thirty million dollar endowment.  Two individual endowed chairs have been established in support of childhood cancer research.  Division Chief Barbara Miller, MD holds the Christopher Millard Endowed chair.

Recently, the Four Diamonds Fund endowed the Four Diamonds Experimental Therapeutic Program, which is dedicated to promote the development of new therapies for children with cancer to improve cure rates and reduce side effects.

Clinical Research

In addition to the basic scientific research that occurs within the labs of The Four Diamonds Research Center at Penn State College of Medicine, the Division of Pediatric Hematology/Oncology is actively involved in the management of clinical trials to treat childhood cancer.

As members of the Children's Oncology Group, the physicians and nurses are involved in the development and management of state-of-the-art protocols used internationally to treat children with cancer.  This provides our patients with access to the most advanced clinical trials available.  It is through this participation by institutions worldwide that the cure rates have improved from fatal diseases to ones that carry an 80% long term survival rate.

A new Experimental Therapeutics Program has recently been endowed to promote the development of new innovative therapies and initiation of clinical trials to improve outcomes.  Learn More

The goal of our program is to offer cutting edge new therapies to children with relapsed tumors. These studies are designed to boost the immune response to fight cancer cells, and are specifically targeted for children with relapsed cancers. Some of our studies use a patient’s or stem cell donors’ blood cells to help stimulate an immune response to cancer proteins. Immunotherapy with a cancer vaccine can be combined with low doses of chemotherapy, which is used to enhance the expression of cancer proteins on tumor cells, thereby making them more likely to be killed by immune cells. Click here to learn more about our immunotherapy program